Sinopharm Of China To Expand Reach With LRT Pharma Buy
This article was originally published in PharmAsia News
Executive Summary
China's Sinopharm Group said it would pay $197 million to buy 60 percent of LRT Pharmaceutical Group as part of an effort to expand its drug distribution business